Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Morris

Showing results (1-10 of 509) with videos related to

Pageof 51
Sort By:
Clinical Advances in Hematology & Oncology : H&O|November 7, 2024
Targeted therapy in prostate cancer: beyond PSMAMichael J Morris
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2015
Failure of ELM-PC 5: an ineffective drug or an unfit end point?Michael J Morris
Nature Clinical Practice. Oncology|October 5, 2006
Paclitaxel and carboplatin versus mitoxantrone: lessons of an underpowered studyMichael J Morris
Clinical Advances in Hematology & Oncology : H&O|May 10, 2018
The timing of molecular imaging in prostate cancerMichael J Morris
Clinical Advances in Hematology & Oncology : H&O|November 14, 2025
The use of PSMA PET/CT imaging as an endpoint in clinical trials of prostate cancerMichael J Morris
American Journal of Respiratory and Critical Care Medicine|November 1, 2014
Reply: Respiratory symptoms in service members returning from Afghanistan and IraqMichael J Morris
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2015
Reply to K. LuMichael J Morris
Clinical Advances in Hematology & Oncology : H&O|December 1, 2023
The National Cancer Institute's Clinical Trials Innovation UnitMichael J Morris, Sheila Prindiville
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 2022
From Concept to Regulatory Drug Approval: Lessons for TheranosticsMarlon Perera, Michael J Morris
Annals of the American Thoracic Society|February 2, 2017
Reply: Excessive Dynamic Airway Collapse: Fact, Fiction, or Flow LimitationMichael J Morris, Septimiu Murgu
Pageof 51

Showing results (1-10 of 509) with videos related to

Sort By:
Pageof 51
Clinical Advances in Hematology & Oncology : H&O|November 7, 2024
Targeted therapy in prostate cancer: beyond PSMAMichael J Morris
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2015
Failure of ELM-PC 5: an ineffective drug or an unfit end point?Michael J Morris
Nature Clinical Practice. Oncology|October 5, 2006
Paclitaxel and carboplatin versus mitoxantrone: lessons of an underpowered studyMichael J Morris
Clinical Advances in Hematology & Oncology : H&O|May 10, 2018
The timing of molecular imaging in prostate cancerMichael J Morris
Clinical Advances in Hematology & Oncology : H&O|November 14, 2025
The use of PSMA PET/CT imaging as an endpoint in clinical trials of prostate cancerMichael J Morris
American Journal of Respiratory and Critical Care Medicine|November 1, 2014
Reply: Respiratory symptoms in service members returning from Afghanistan and IraqMichael J Morris
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2015
Reply to K. LuMichael J Morris
Clinical Advances in Hematology & Oncology : H&O|December 1, 2023
The National Cancer Institute's Clinical Trials Innovation UnitMichael J Morris, Sheila Prindiville
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 2022
From Concept to Regulatory Drug Approval: Lessons for TheranosticsMarlon Perera, Michael J Morris
Annals of the American Thoracic Society|February 2, 2017
Reply: Excessive Dynamic Airway Collapse: Fact, Fiction, or Flow LimitationMichael J Morris, Septimiu Murgu
Pageof 51